Intestinal fibrosis in IBD--a dynamic, multifactorial process
- PMID: 19347014
- DOI: 10.1038/nrgastro.2009.31
Intestinal fibrosis in IBD--a dynamic, multifactorial process
Abstract
Intestinal fibrosis is a common and potentially serious complication of IBD that results from the reaction of intestinal tissue to the damage inflicted by chronic inflammation. The traditional view that fibrosis is inevitable or irreversible in patients with IBD is progressively changing in light of improved understanding of the cellular and molecular mechanisms that underlie the pathogenesis of fibrosis in general, and, in particular, intestinal fibrosis. These mechanisms are complex and dynamic, and involve multiple cell types, interconnected cellular events and a large number of soluble factors. In addition, owing to a breakdown of the epithelial barrier during inflammation of the gut, luminal bacterial products induce an innate immune response, which is triggered by activation of immune and nonimmune cells alike. Comprehension of the mechanisms of intestinal fibrosis will create a conceptual and practical framework that could achieve the specific blockade of fibrogenic pathways, allow for the estimation of risk of fibrotic complications, permit the detection of early fibrotic changes and, eventually, enable the development of treatments customized to the type and stage of each patient's IBD.
Similar articles
-
Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.Dig Dis. 2017;35(1-2):25-31. doi: 10.1159/000449079. Epub 2017 Feb 1. Dig Dis. 2017. PMID: 28147352 Review.
-
Can we prevent, reduce or reverse intestinal fibrosis in IBD?Eur Rev Med Pharmacol Sci. 2013 May;17(10):1283-304. Eur Rev Med Pharmacol Sci. 2013. PMID: 23740440 Review.
-
Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease.PLoS One. 2018 Jul 11;13(7):e0200377. doi: 10.1371/journal.pone.0200377. eCollection 2018. PLoS One. 2018. PMID: 29995938 Free PMC article.
-
Mechanisms of tissue remodeling in inflammatory bowel disease.Dig Dis. 2013;31(2):186-93. doi: 10.1159/000353364. Epub 2013 Sep 6. Dig Dis. 2013. PMID: 24030223 Review.
-
Inflammation accelerating intestinal fibrosis: from mechanism to clinic.Eur J Med Res. 2024 Jun 18;29(1):335. doi: 10.1186/s40001-024-01932-2. Eur J Med Res. 2024. PMID: 38890719 Free PMC article. Review.
Cited by
-
Hepatic Gα13 ablation shifts region-specific colonic inflammatory status by modulating the bile acid synthetic pathway in mice.Sci Rep. 2024 Aug 23;14(1):19580. doi: 10.1038/s41598-024-70254-4. Sci Rep. 2024. PMID: 39179591 Free PMC article.
-
Prostatic fibrosis, lower urinary tract symptoms, and BPH.Nat Rev Urol. 2013 Sep;10(9):546-50. doi: 10.1038/nrurol.2013.149. Epub 2013 Jul 16. Nat Rev Urol. 2013. PMID: 23857178 Free PMC article. Review.
-
Comparative transcriptome and microbiota analyses provide new insights into the adverse effects of industrial trans fatty acids on the small intestine of C57BL/6 mice.Eur J Nutr. 2021 Mar;60(2):975-987. doi: 10.1007/s00394-020-02297-y. Epub 2020 Jun 20. Eur J Nutr. 2021. PMID: 32564148
-
New understanding of gut microbiota and colorectal anastomosis leak: A collaborative review of the current concepts.Front Cell Infect Microbiol. 2022 Nov 1;12:1022603. doi: 10.3389/fcimb.2022.1022603. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36389160 Free PMC article. Review.
-
The Charming World of the Extracellular Matrix: A Dynamic and Protective Network of the Intestinal Wall.Front Med (Lausanne). 2021 Apr 16;8:610189. doi: 10.3389/fmed.2021.610189. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33937276 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources